Results 91 to 100 of about 5,511 (190)

Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action

open access: yesThe Egyptian Journal of Internal Medicine, 2015
Background The non-calcium-based phosphate binder sevelamer hydrochloride was developed to provide chronic kidney disease patients with a polymer capable of managing hyperphosphatemia without an increase in the calcium load.
Bahaa Eldin Zayed   +5 more
doaj   +1 more source

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease [PDF]

open access: yes, 2013
Chronic kidney disease (CKD) patients are given calcium carbonate to bind dietary phosphorus and reduce phosphorus retention, and to prevent negative calcium balance. Data are limited on calcium and phosphorus balance in CKD to support this.
Hill, Kathleen M.   +6 more
core   +1 more source

Calcific uraemic arteriolopathy - A mini-review [PDF]

open access: yes, 2016
Calcific Uraemic Arteriolopathy (CUA) or calciphylaxis, is a thrombotic disorder of skin and subcutaneous tissue which typically presents with painful purpuric nodules that may progress to necrotic ulcers, and is a severe, life-threatening condition. CUA
Agapii, Rodica   +7 more
core  

New therapies: calcimimetics, phosphate binders and vitamin D receptor activators [PDF]

open access: yes, 2010
At present, new compounds are available to treat secondary hyperparathyroidism, namely calcimimetics, novel phosphorus binders and also novel vitamin D receptor activactors.
Cannata, J.B. (Jorge)   +5 more
core  

Interleukin-18 enhances vascular calcification and osteogenic differentiation of vascular smooth muscle cells through TRPM7 channel activation [PDF]

open access: yes, 2017
Objective—Vascular calcification (VC) is an important predictor of cardiovascular morbidity and mortality. Osteogenic differentiation of vascular smooth muscle cells (VSMCs) is a key mechanism of VC. Recent studies show that IL-18 (interleukin-18) favors
Chen, Jie   +7 more
core   +1 more source

Sulfonic acid-functionalized polyallylamine (sevelamer) as an efficient reusable strong solid acid catalyst for the synthesis of xanthenes derivatives

open access: yesBMC Chemistry, 2019
Sevelamer (polyallyamine resin)-supported sulfonic acid (S-SO3H) has been prepared from the reaction of sevelamer with chlorosulfonic acid and characterized using FT-IR spectroscopy, scanning electronmicroscopy (SEM) and thermogravimetric analysis (TGA).
Xian-Liang Zhao   +2 more
doaj   +1 more source

A 60-year-old man with chronic renal failure and a costal mass: a case report and review of the literature [PDF]

open access: yes, 2009
Introduction Brown tumors are a rare focal manifestation of osteitis fibrosa cystica, which results from hyperparathyroidism. Chronic kidney failure may lead to secondary or tertiary hyperparathyroidism and thus to osteitis fibrosa cystica and brown ...
Germán Campuzano-Zuluaga   +2 more
core   +1 more source

A Case of Crystal-Associated Colitis Caused by Sevelamer

open access: yesAnnals of Internal Medicine: Clinical Cases
Sevelamer, a calcium-free phosphate binder used in chronic kidney disease, can lead to gastrointestinal side effects and, rarely, crystal-associated colitis. We present a case of sevelamer-induced colitis in a 66-year-old man with end-stage renal disease.
Ryan Plunkett   +5 more
doaj   +1 more source

Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo

open access: yesNefrología, 2015
El sevelamer es un captor no cálcico de fósforo que se utiliza en la ERC avanzada y en diálisis para el control de la hiperfosforemia. Varios estudios experimentales, observacionales y ensayos clínicos han mostrado que el sevelamer tiene efectos ...
Laura Rodríguez-Osorio   +6 more
doaj   +1 more source

Meta analysis of efficiency and safety of sevelamer in the treatment of hyperphosphatemia in patients with maintenance hemodialysis

open access: yesLinchuang shenzangbing zazhi, 2018
Objective The objective of this review is to inquire the efficiency and safety of sevelamer to decrease the level of serum phosphate of the patients with maintenance hemodialysis.Methods According to the strict inclusion and exclusion criteria we search ...
YANG Ling
doaj  

Home - About - Disclaimer - Privacy